Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $3.92
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 01, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 $3.92
Jun 24, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 10,000 $3.84
Jun 04, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 10,000 $3.96
Apr 20, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $5.05
Apr 20, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $5.05
Apr 20, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $5.05
Apr 20, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $5.05
Apr 20, 2010
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $5.05
Apr 19, 2010
Director
Director Open market or private purchase of non-derivative or derivative security 4,000 $4.83
Apr 12, 2010
Director
Director Open market or private purchase of non-derivative or derivative security 2,500 $4.57
Apr 09, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 10,000 $4.44
Feb 05, 2010
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 $4.39
Feb 03, 2010
Director
Director Open market or private purchase of non-derivative or derivative security 20,000 $4.52
Jan 08, 2010
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $4.65
Jan 08, 2010
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jan 08, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 $4.65
Jan 08, 2010
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 200,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.